Clinical Trials Directory

Trials / Completed

CompletedNCT01461590

Study of Safe Blood Transfusion Volumes to Correct Acute Severe Anaemia

Phase II Trial of Transfusion Volumes in Children With Acute Severe Anaemia

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Prof Kathryn Maitland · Academic / Other
Sex
All
Age
60 Days – 12 Years
Healthy volunteers
Not accepted

Summary

Greater volume of whole blood(30mls/kg compared to 20mls/kg) following standard calculations, given to children with severe anaemia will be beneficial in haematological correction and can be given safely since respiratory distress and haemodynamic changes result from acidosis and compensation in these children rather than from biventricular failure.

Detailed description

Severe anemia (SA, hemoglobin \<6 g/dl) is a leading cause of pediatric hospital admission in Africa, with significant in-hospital mortality. The underlying etiology is often infectious, but specific pathogens are rarely identified. Guidelines developed to encourage rational blood use recommend a standard volume of whole blood (20 ml/kg) for transfusion, but this is commonly associated with a frequent need for repeat transfusion and poor outcome. Evidence is lacking on what haemoglobin threshold criteria for intervention and volume are associated with the optimal survival outcomes. We evaluated the safety and efficacy of a higher volume of whole blood (30 ml/kg; Tx30: n = 78) against the standard volume (20 ml/kg; Tx20: n = 82) in Ugandan children (median age 35.5 months (interquartile range (IQR) 12.5 to 52.5)) for 24-hour anemia correction (hemoglobin \>6 g/dl: primary outcome) and 28-day survival.

Conditions

Interventions

TypeNameDescription
OTHERWhole blood30mls/kg transfused over fours hours
OTHERWhole blood20mls/kg transfused over four hours

Timeline

Start date
2011-10-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2011-10-28
Last updated
2015-04-01

Locations

2 sites across 1 country: Uganda

Source: ClinicalTrials.gov record NCT01461590. Inclusion in this directory is not an endorsement.